Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FDA's Food Advisory Committee

This article was originally published in The Tan Sheet

Executive Summary

FDA's Food Advisory Committee: Plans to discuss a number of dietary supplement issues at Feb. 11-13 meeting, including two issues raised in the final report of the President's Commission on Dietary Supplement Labeling: post-market surveillance and consumer research. The group also will focus on aspects of Good Manufacturing Practices for supplements. "The agency is interested in recommendations for ensuring the identity for different types of dietary ingredients and on record-keeping requirements," the meeting notice says. The meeting is scheduled for 8:30-5 at the Doubletree Hotel, Pentagon City, Arlington, Va. For more information contact FDA's Catherine DeRoever at (202) 205-4251...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087946

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel